Publications

Journal Article
Multicenter Study
Epublish 3 citations
Electronic publication date
July 6, 2025

View on Pubmed.gov 40617583 | View on doi.org 10.1136/rmdopen...

Clusters in paediatric Behçet's disease: a multicentre international study.

Search for publications in this journal RMD Open

Abstract

OBJECTIVES

Clinical features of Behçet's disease (BD) exhibit significant variability, not only from patient to patient but also according to gender and geographical region. This study aims to describe the clinical characteristics, identify distinct clusters in a large cohort of paediatric BD patients and compare the clinical manifestations of patients across three geographical regions: Turkey, Europe and Iran.

METHOD

Patients with paediatric-onset BD (<18 years of age) from Turkey, Iran and European countries (France and Italy) were retrospectively evaluated. A follow-up period of at least 6 months was required for inclusion.

RESULTS

The study included 600 patients (297 females, 49.5%), with cases from Turkey (n=231), Iran (n=306), France (n=44) and Italy (n=19). The most common presentations were mucocutaneous involvement (97.5%), followed by ocular (48.0%), musculoskeletal (43.2%), neurological (11.8%), vascular (11.5%), gastrointestinal (9.0%) and cardiac (2.0%) involvement. Ocular involvement was more prevalent in Iran, gastrointestinal involvement in Europe, and musculoskeletal and vascular involvement in Turkey compared with the other geographical regions. Seven distinct clusters of paediatric BD as vascular (cluster 1 (C1)), mucocutaneous only (C2), ocular (C3), gastrointestinal (C4), mixed (C5), neurologic and ocular (C6), and mucocutaneous-musculoskeletal cluster (C7) were identified, although there was some overlap in system involvements.

CONCLUSIONS

Our study supports the notion that BD may tend to present in certain clusters in children as well. Since BD is a complex disease with a multifactorial aetiology, involving the interaction of pathogenic pathways, classification of clusters presents a significant challenge. We have also shown that certain clinical features vary among geographical regions.

References

Front Med (Lausanne). 2021 Oct 08;8:713052

Mod Rheumatol. 2023 Apr 13;33(3):574-578

Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S48-51

Intern Emerg Med. 2020 Sep;15(6):1031-1039

Conflict of interest statement

Competing interests: None declared.

MeSH

Specialties

Copyright

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.